Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y T Khoo

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Experimental Dermatology|April 18, 2007
mTOR as a potential therapeutic target for treatment of keloids and excessive scarsC T Ong, Y T Khoo, A Mukhopadhyay, et al.
The British Journal of Dermatology|February 5, 2010
Comparative proteomic analysis between normal skin and keloid scarC T Ong, Y T Khoo, A Mukhopadhyay, et al.
The Journal of Pathology|December 1, 2006
Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretionC T Ong, Y T Khoo, E K Tan, et al.
The British Journal of Dermatology|September 18, 2010
The role of stem cell factor and c-KIT in keloid pathogenesis: do tyrosine kinase inhibitors have a potential therapeutic role?A Mukhopadhyay, D V Do, C T Ong, et al.
The British Journal of Dermatology|November 5, 2011
Interleukin-18 system plays an important role in keloid pathogenesis via epithelial-mesenchymal interactionsD V Do, C T Ong, Y T Khoo, et al.
Mbio|May 7, 2015
Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteriaWilfried Moreira, Grace J Y Ngan, Jian Liang Low, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Experimental Dermatology|April 18, 2007
mTOR as a potential therapeutic target for treatment of keloids and excessive scarsC T Ong, Y T Khoo, A Mukhopadhyay, et al.
The British Journal of Dermatology|February 5, 2010
Comparative proteomic analysis between normal skin and keloid scarC T Ong, Y T Khoo, A Mukhopadhyay, et al.
The Journal of Pathology|December 1, 2006
Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretionC T Ong, Y T Khoo, E K Tan, et al.
The British Journal of Dermatology|September 18, 2010
The role of stem cell factor and c-KIT in keloid pathogenesis: do tyrosine kinase inhibitors have a potential therapeutic role?A Mukhopadhyay, D V Do, C T Ong, et al.
The British Journal of Dermatology|November 5, 2011
Interleukin-18 system plays an important role in keloid pathogenesis via epithelial-mesenchymal interactionsD V Do, C T Ong, Y T Khoo, et al.
Mbio|May 7, 2015
Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteriaWilfried Moreira, Grace J Y Ngan, Jian Liang Low, et al.
Pageof 1